Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 2,8412,860 of 20,252 grants

Active RESEARCH CENTERS
Product Evaluation and Manipulation Core (PEMC)
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2028

PROJECT SUMMARY – PRODUCT EVALUATION AND MANIPULATION CORE The goal of the Product Evaluation and Manipulation Core (PEMC) is to support and complement the human research conducted...

Active RESEARCH CENTERS
Marketing Monitoring Core (MMC)
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2028

PROJECT SUMMARY – MARKET MONITORING CORE The landscape of the tobacco market continues to increase in complexity by product and design, with the intent to maintain tobacco use and...

Completed NON-SBIR/STTR RPGS
Mitochondrial Dysfunction underlies treatment related hepatotoxicity in Hispanics with acute lymphoblastic leukemia
NATIONAL CANCER INSTITUTE University of Southern California United States 2023 – 2025

PROJECT TITLE: Mitochondrial dysfunction underlies treatment related hepatotoxicity in Hispanics with acute lymphoblastic leukemia ABSTRACT: Acute Lymphoblastic leukemia is the mos...

$4.42M
USD
Completed TRAINING, INDIVIDUAL
HARNESSING IN VIVO CLICK CHEMISTRY FOR 211AT-BASED PRETARGETED RADIOIMMUNOTHERAPY
NATIONAL CANCER INSTITUTE Hunter College United States 2023 – 2024

PROJECT SUMMARY/ABSTRACT Over the last fifteen years, radioimmunotherapy (RIT) using antibodies labeled with a-emitting radionuclides has shown significant promise for the treatmen...

$292.7K
USD
Completed SBIR-STTR RPGS
Minimally invasive quantitative tissue oxygen sensors to personalize cancer care
NATIONAL CANCER INSTITUTE Stratagen Bio, Inc United States 2023 – 2025

Project Summary and Abstract Hypoxic (oxygen depleted) tumors are more resistant to treatments including radiation therapy. This trend has been seen across a wide range of cancers...

$4M
USD
Active NON-SBIR/STTR RPGS
A Multi-Institute Survivorship Study of Patients Living with Advanced Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors
NATIONAL CANCER INSTITUTE Roswell Park Cancer Institute Corp United States 2023 – 2028

ABSTRACT Immune checkpoint inhibitors (ICIs) have markedly transformed the therapeutic landscape for many types of advanced malignancies over the past decade. A sizable proportion...

$8.16M
USD
Active NON-SBIR/STTR RPGS
A Bioprinted Volumetric Model of Vascularized Glioblastoma
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2023 – 2028

Abstract The dynamic tumor microenvironment (TME) where cells continuously communicate, migrate, and react to each other and the signals that are secreted, is critical for inducing...

$4.46M
USD
Active NON-SBIR/STTR RPGS
Targeting MALT1 to Enhance Anti-Lymphoma Immunity and Response to Immunotherapy
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2023 – 2028

ABSTRACT Diffuse large B-cell lymphoma (DLBCL) is the most frequent B-cell non-Hodgkin lymphoma (B-NHL). The treatment of these diseases remains challenging, with many patients ult...

$4.79M
USD
Completed SBIR-STTR RPGS
A Phase 2, randomized, double-blind, 4-arm, multicenter study to demonstrate the efficacy and safety of topical dosage formulations of a prescription drug product for actinic keratosis
NATIONAL CANCER INSTITUTE Nanometics, Llc United States 2023 – 2025

PROJECT SUMMARY / ABSTRACT Acinic Keratoses (AK) are premalignant skin lesions with the potential to develop into Cutaneous Squamous cell Carcinoma (CSCC), which is the second most...

$10M
USD
Active SBIR-STTR RPGS
Developing and Automating an Extracellular Vesicle-Based Test for Early Detection of Hepatocellular Carcinoma
NATIONAL CANCER INSTITUTE Eximius Diagnostics Corp United States 2023 – 2026

PROJECT SUMMARY Hepatocellular carcinoma (HCC) comprises 80-85% of primary liver cancers and frequently develops in patients with liver cirrhosis or chronic hepatitis B virus infec...

$6.62M
USD
Active RESEARCH CENTERS
Project 1: Manipulating E-cigarette Nicotine to Promote Public Health
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2028

PROJECT SUMMARY – PROJECT 1 Historically, the tobacco industry manipulated nicotine in cigarettes to promote smoking. They are now following the same playbook for e-cigarettes (ECs...

Active RESEARCH CENTERS
Project 2: Informing oral nicotine pouch regulations to promote public health
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2028

PROJECT SUMMARY – PROJECT 2 Historically, the tobacco industry manipulated nicotine concentration and form to offer a range of smokeless tobacco (ST) products to appeal to both new...

Active RESEARCH CENTERS
Project 3: Nicotine Product Claims on Appeal, Perceptions, and Use Behavior
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2028

SUMMARY – PROJECT 3 Oral nicotine pouches (ONPs) emerged in the U.S. in 2016, ONP brands rapidly proliferated, and sales are skyrocketing. ONPs are representative of a shift by the...

Active RESEARCH CENTERS
Project 4: A Naturalistic Observation of Electronic Cigarettes and Oral Nicotine Pouch Product Use Among Adolescents and Young Adults
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2028

PROJECT SUMMARY – PROJECT 4 The tobacco product landscape changed drastically in the last decade with the proliferation of non-combustible tobacco products like e-cigarettes (ECs)...

Active RESEARCH CENTERS
Administrative Core (AC)
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2028

PROJECT SUMMARY - ADMINISTRATIVE CORE The Administrative Core (AC) will provide a structure to facilitate effective and integrative interactions between the TCORS team. The AC will...

Active RESEARCH CENTERS
Career Enhancement Core
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2028

PROJECT SUMMARY - CAREER ENHANCEMENT CORE The goal of the Career Enhancement Core (CEC) is to foster the development of researchers planning to engage in the field of tobacco regul...

Active RESEARCH CENTERS
Product Evaluation and Manipulation Core (PEMC)
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2028

PROJECT SUMMARY – PRODUCT EVALUATION AND MANIPULATION CORE The goal of the Product Evaluation and Manipulation Core (PEMC) is to support and complement the human research conducted...

Active RESEARCH CENTERS
Marketing Monitoring Core (MMC)
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2028

PROJECT SUMMARY – MARKET MONITORING CORE The landscape of the tobacco market continues to increase in complexity by product and design, with the intent to maintain tobacco use and...

Active NON-SBIR/STTR RPGS
A Multi-Institute Survivorship Study of Patients Living with Advanced Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors
NATIONAL CANCER INSTITUTE Roswell Park Cancer Institute Corp United States 2023 – 2028

ABSTRACT Immune checkpoint inhibitors (ICIs) have markedly transformed the therapeutic landscape for many types of advanced malignancies over the past decade. A sizable proportion...

$7.35M
USD
Active OTHER RESEARCH-RELATED
Immune control of oncogene selection in preneoplastic colon
NATIONAL CANCER INSTITUTE Yale University United States 2023 – 2028

Colon cancers develop by stepwise accumulation of oncogenic mutations in epithelial stem cells. These mutated stem cells multiply by positive selection in healthy colon for years b...

$1.85M
USD